Opaleye Management reports acquisition of $83,435.0168 in Grace Therapeutics common shares
GRCE•Opaleye Management, a 10% owner of Grace Therapeutics, purchased 48,060 common shares for $83,435.0168. Indirect beneficial ownership through Opaleye, L.P. rose to 3,102,904 shares.
1. Share purchase
Opaleye Management, a 10% owner of Grace Therapeutics, purchased 48,060 shares of common stock for $83,435.0168. Indirect beneficial ownership through Opaleye, L.P. rose to 3,102,904 shares.




